TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 05/01/23

2023-05-01 23:53:08 ET Summary My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends, and risk stocks for a happy retirement. Great performances by Arrowhead Pharmaceuticals and Meta propelled my portfolio again to all-time highs and mar...

2023-04-27 09:44:03 ET The U.S. Food and Drug Administration (FDA) accepted for review Takeda's resubmitted application seeking approval for subcutaneous (SC) administration of Entyvio as a maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) after...

Takeda ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) resubmission for the investigational subcutaneous (SC) administration of Entyvio ® (vedol...

WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company (TSE:4502/NYSE:TAK) (“Takeda”) to acquire the TachoSil manufacturing operations in Linz, Austria....

2023-04-22 16:00:00 ET Treatments for ulcerative colitis (UC) are projected to reach $9.6B in eight major markets by 2031 driven by an increase in the patient population and new therapies coming to market. That's the assessment from data and analytics firm GlobalData, which sees a 2...

2023-04-20 07:26:38 ET Takeda Canada said it signed a three-year agreement with Canadian Blood Services (CBS) for immunoglobulin therapies to treat immunodeficiency diseases. The Takeda Pharmaceutical's ( NYSE: TAK ) Canadian unit's agreement includes Gammagard Liqui...

Takeda has Secured Three-Year Contract in Key Immunoglobulin Category Canada NewsWire Takeda continues its commitment to delivering innovative therapies that allow Canadians with primary and secondary immunodeficiency to live their lives to the fullest TORONTO ...

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J. , April 17, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that its New Drug Application (“NDA”) for fruquintinib in combination with pa...

2023-04-14 05:32:00 ET Ghana became the first country globally to approve a new malaria vaccine developed by the Oxford University, BBC reported. Ghana's Food and Drugs Authority approved the vaccine, dubbed R21, for use in children between five months to three years old. The Africa...

2023-04-13 05:02:47 ET A federal appeals court blocked part of a Texas court's ruling that would halt the access to the abortion pill mifepristone. Earlier this week, the U.S. Justice Department (DOJ) had asked the U.S. 5th Circuit Court of Appeals to halt U.S. Judge Matthew Kacsmar...